Jeffrey Yeh is an experienced all-rounded entrepreneur, with over 21 years’ experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management. Jeffrey co-founded Homart Pharmaceuticals in 2002, and since then has grown Homart into a premier and award winning manufacturing and brand business with over 200 employees and an international presence.
Jeffrey Yeh
February 21, 2024
RECENT POSTS
- Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
- Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024
- Wellnex ready for dual UK listing in new year after record November sales
- ASX wellness stocks offering calm and anxiety relief – Part 2
- Wellnex Life (ASX:WNX) Q&A – 9th February 2024
